231 related articles for article (PubMed ID: 17433788)
41. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon.
Yamashita N; Minamoto T; Ochiai A; Onda M; Esumi H
Gastroenterology; 1995 Feb; 108(2):434-40. PubMed ID: 7835585
[TBL] [Abstract][Full Text] [Related]
42. Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.
Roncucci L; Pedroni M; Vaccina F; Benatti P; Marzona L; De Pol A
Cell Prolif; 2000 Feb; 33(1):1-18. PubMed ID: 10741640
[TBL] [Abstract][Full Text] [Related]
43. Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine.
Kowalczyk M; Orłowski M; Klepacki Ł; Zinkiewicz K; Kurpiewski W; Kaczerska D; Pesta W; Zieliński E; Siermontowski P
BMC Cancer; 2020 Feb; 20(1):133. PubMed ID: 32075595
[TBL] [Abstract][Full Text] [Related]
44. Genomic instability of human aberrant crypt foci measured by inter-(simple sequence repeat) PCR and array-CGH.
Alrawi SJ; Carroll RE; Hill HC; Gibbs JF; Tan D; Brenner BM; Nowak NJ; Swede H; Stoler DL; Anderson GR
Mutat Res; 2006 Oct; 601(1-2):30-8. PubMed ID: 16806294
[TBL] [Abstract][Full Text] [Related]
45. Significance and role of early-lesions in experimental colorectal carcinogenesis.
Mori H; Hata K; Yamada Y; Kuno T; Hara A
Chem Biol Interact; 2005 Jun; 155(1-2):1-9. PubMed ID: 15904905
[TBL] [Abstract][Full Text] [Related]
46. Screening for colorectal cancer: does it all start with aberrant crypt foci?
Rasheed S; Rigas B
Gastrointest Endosc; 2008 Jun; 67(7):1103-5. PubMed ID: 18513552
[No Abstract] [Full Text] [Related]
47. Aberrant crypt foci as precursors in colorectal cancer progression.
Orlando FA; Tan D; Baltodano JD; Khoury T; Gibbs JF; Hassid VJ; Ahmed BH; Alrawi SJ
J Surg Oncol; 2008 Sep; 98(3):207-13. PubMed ID: 18623110
[TBL] [Abstract][Full Text] [Related]
48. Aberrant crypt foci in the adenoma prevention with celecoxib trial.
Cho NL; Redston M; Zauber AG; Carothers AM; Hornick J; Wilton A; Sontag S; Nishioka N; Giardiello FM; Saltzman JR; Gostout C; Eagle CJ; Hawk ET; Bertagnolli MM
Cancer Prev Res (Phila); 2008 Jun; 1(1):21-31. PubMed ID: 19138933
[TBL] [Abstract][Full Text] [Related]
49. Endoscopy, morphology, morphometry and molecular markers: predicting cancer risk in colorectal adenoma.
Søreide K; Nedrebø BS; Reite A; Thorsen K; Kørner H
Expert Rev Mol Diagn; 2009 Mar; 9(2):125-37. PubMed ID: 19298137
[TBL] [Abstract][Full Text] [Related]
50. Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic disease.
Bouzourene H; Chaubert P; Seelentag W; Bosman FT; Saraga E
Hum Pathol; 1999 Jan; 30(1):66-71. PubMed ID: 9923929
[TBL] [Abstract][Full Text] [Related]
51. Predictive value of rectal aberrant crypt foci for intraepithelial neoplasia in ulcerative colitis - a cross-sectional study.
Freire P; Figueiredo P; Cardoso R; Manuel Donato M; Ferreira M; Mendes S; Silva MR; Cipriano MA; Ferreira AM; Vasconcelos H; Portela F; Sofia C
Scand J Gastroenterol; 2014 Oct; 49(10):1219-29. PubMed ID: 25157637
[TBL] [Abstract][Full Text] [Related]
52. The adenoma-carcinoma sequence in colorectal neoplasia.
O'Brien MJ; Gibbons D
Surg Oncol Clin N Am; 1996 Jul; 5(3):513-30. PubMed ID: 8829316
[TBL] [Abstract][Full Text] [Related]
53. Effect of folic acid supplementation on the progression of colorectal aberrant crypt foci.
Lindzon GM; Medline A; Sohn KJ; Depeint F; Croxford R; Kim YI
Carcinogenesis; 2009 Sep; 30(9):1536-43. PubMed ID: 19541855
[TBL] [Abstract][Full Text] [Related]
54. Identification of dysplasia in human colonic aberrant crypt foci.
Siu IM; Pretlow TG; Amini SB; Pretlow TP
Am J Pathol; 1997 May; 150(5):1805-13. PubMed ID: 9137103
[TBL] [Abstract][Full Text] [Related]
55. Aberrant crypt foci in colon cancer epidemiology.
Khare S; Chaudhary K; Bissonnette M; Carroll R
Methods Mol Biol; 2009; 472():373-86. PubMed ID: 19107443
[TBL] [Abstract][Full Text] [Related]
56. Quantitative study of the precancerous and malignant lesions in colorectal adenomas.
Ranaldi R; Bearzi I; Santinelli A; Mannello B; Mariuzzi GM
Pathol Res Pract; 1992 Jun; 188(4-5):561-4. PubMed ID: 1409089
[TBL] [Abstract][Full Text] [Related]
57. Identification of High-Risk Aberrant Crypt Foci and Mucin-Depleted Foci in the Human Colon With Study of Colon Cancer Stem Cell Markers.
Gupta B; Das P; Ghosh S; Manhas J; Sen S; Pal S; Sahni P; Upadhyay AD; Panda SK; Gupta SD
Clin Colorectal Cancer; 2017 Sep; 16(3):204-213. PubMed ID: 27789195
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of Difluoromethylornithine and Aspirin for Treatment of Adenomas and Aberrant Crypt Foci in Patients with Prior Advanced Colorectal Neoplasms.
Sinicrope FA; Velamala PR; Song LMWK; Viggiano TR; Bruining DH; Rajan E; Gostout CJ; Kraichely RE; Buttar NS; Schroeder KW; Kisiel JB; Larson MV; Sweetser SR; Sedlack RR; Sinicrope SN; Richmond E; Umar A; Della'Zanna G; Noaeill JS; Meyers JP; Foster NR
Cancer Prev Res (Phila); 2019 Nov; 12(11):821-830. PubMed ID: 31484660
[TBL] [Abstract][Full Text] [Related]
59. Role of inducible nitric oxide synthase expression in aberrant crypt foci-adenoma-carcinoma sequence.
Xu MH; Deng CS; Zhu YQ; Lin J
World J Gastroenterol; 2003 Jun; 9(6):1246-50. PubMed ID: 12800233
[TBL] [Abstract][Full Text] [Related]
60. Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients.
Kowalczyk M; Orłowski M; Siermontowski P; Mucha D; Zinkiewicz K; Kurpiewski W; Zieliński E; Kowalczyk I; Pedrycz A
BMC Cancer; 2018 Feb; 18(1):213. PubMed ID: 29466973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
